BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27610545)

  • 1. FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Ren Y; Lence-Anta JJ; Pereda CM; Chappe M; Velasco M; Infante I; Bustillo M; Turcios S; Leufroy A; Guérin T; Noël L; Lesueur F; Maillard S; Cléro E; Xhaard C; Allodji RS; Rubino C; Rodriguez R; Ortiz RM; de Vathaire F
    Thyroid; 2016 Dec; 26(12):1752-1760. PubMed ID: 27610545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
    Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
    BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
    Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
    PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXE1 association with differentiated thyroid cancer and its progression.
    Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
    Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
    Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study.
    Cléro É; Doyon F; Chungue V; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Dewailly E; Rubino C; de Vathaire F
    Thyroid; 2012 Apr; 22(4):422-9. PubMed ID: 22280227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
    Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
    Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the association between FOXE1 gene polymorphism and differentiated thyroid cancer: a meta-analysis.
    Chen YH; Zhang YQ
    BMC Med Genet; 2018 May; 19(1):83. PubMed ID: 29788924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
    Sturgis EM; Zhao C; Zheng R; Wei Q
    Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
    Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
    Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer.
    Marcello MA; Sampaio AC; Geloneze B; Vasques AC; Assumpção LV; Ward LS
    Nutr Cancer; 2012; 64(8):1190-5. PubMed ID: 23163848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FOXE1 polyalanine repeat region with thyroid cancer is dependent on tumour size.
    Raimundo J; Alvelos MI; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):243-246. PubMed ID: 27474100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
    Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
    Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
    He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
    Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
    Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
    He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study on differentiated thyroid cancer.
    Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
    Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
    Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.